All Infection Prevention & Control articles – Page 10
-
NewsTargeted nanoparticles show promise for more effective antifungal treatments
Researchers have developed a new nanotechnology-based approach that could improve treatment of fungal infections, particularly those caused by the increasingly drug-resistant Candida species.
-
NewsCOVID-19 caused by the Omicron variant in lung transplant recipients: a single center case series
A new study investigates the risk factors for developing severe disease in lung transplant patients as a result of the Omicron variant of Covid-19.
-
NewsTissue geometry drives bacterial infection: new mechanism uncovered
Researrchers have uncovered a novel mechanism by which tissue geometry regulates bacterial infection dynamics. The study employs a multidisciplinary approach to reveal how host tissue structure, mechanical forces, and cellular signaling shape infection patterns.
-
NewsNovel point of attack to combat dangerous tropical diseases
Researchers have compiled a high-precision inventory of the membrane proteins of cell organelles of the African sleeping sickness pathogen, offering hope for new treatment approaches for dangerous tropical diseases.
-
NewsDiscovery opens up for new ways to treat chlamydia
Researchers have discovered a type of molecule that can kill chlamydia bacteria but spare bacteria that are important for health.
-
NewsScientists engineer antibody against flu with sticky staying power
Scientists have engineered a monoclonal antibody that can protect mice from a lethal dose of influenza A, a new study shows. The new molecule combines the specificity of a mature flu fighter with the broad binding capacity of a more general immune system defender. Source: NIAID Colorized transmission ...
-
NewsTransforming hospital sanitation: autonomous robots for wiping and UV-C disinfection
Scientists have developed an ’Intelligent Autonomous Wiping and UV-C Disinfection Robot’ capable of automating hospital disinfection processes. The system can perform disinfection with consistent precision, significantly reducing the risk of infection within the hospital.
-
NewsScientists discover antibiotic resistance in newly identified bacterium
Staphylococcus borealis has been found to be resistant to several different types of antibiotics, posing a potentially significant problem for the elderly.
-
NewsResearch collaboration takes ‘one health’ approach to study Chagas disease
Researchers have received more than $4 million from federal and non-governmental organizations to support research on Chagas disease prevalence, diagnostics and treatment to benefit both dogs and humans.
-
NewsDisease experts call for reinstatement of CDC’s Healthcare Infection Control Practices Advisory Committee (HICPAC)
The Society for Healthcare Epidemiology of America has called for the reinstatement of CDC’s Healthcare Infection Control Practices Advisory Committee (HICPAC), warning that decades of progress in preventing healthcare-associated infections are under threat.
-
OpinionIt’s game over for dangerous Gain of Function research
The Trump adminstration has signed an Executive Order halting federal gain of function research on microbes - but does it throw the baby out with the bathwater? Virologist Simon Wain-Hobson, Emeritus Professor with the Pasteur Institute, Paris, gives his take.
-
NewsFood as medicine: How diet shapes gut microbiome health
New research shows how mice fed a Western-style diet are not able to rebuild a ‘healthy’, diverse gut microbiome following antibiotic treatment. These mice were also more susceptible to infection by pathogens like Salmonella.
-
NewsClinical trial underway for potential Long COVID treatment
A clinical trial is underway to assess the effectiveness and safety of sipavibart, AstraZeneca’s long-acting monoclonal antibody designed to provide protection against Covid-19, as a potential treatment for Long Covid.
-
NewsTopical gel relieved ear infections in animals after just one dose
Researchers report a topical antibiotic gel that, applied once, cured middle ear infection within 24 hours in chinchillas. a single dose of treatment for middle ear infections could improve patient compliance and potentially reduce pediatric antibiotic usage.
-
NewsBarriers remain to peptide-based therapies - but there are answers, reveals study
Peptide-based therapies offer the potential to transform how we treat a range of conditions - but have yet to be adopted for widespread clinical use. A new review uncovers the barriers to adoption and identifies ways to overcome these limitations.
-
NewsMonoclonal antibody nirsevimab provides strong protection against severe RSV in infants
Nirsevimab, a monoclonal antibody, is highly effective in real-world conditions at preventing severe respiratory syncytial virus (RSV) infections in infants, suggests a meta-analysis.
-
NewsLong COVID biomarkers found – associated with respiratory problems
Researchers have identified biomarkers in the blood associated with symptoms of long COVID, particularly severe respiratory disorders. The discovery can pave the way for future diagnosis and treatment.
-
NewssiRNA plus nanovaccine yields stable functional cure for chronic hepatitis B
Researchers have developed an innovative therapy for chronic hepatitis B, synergistically combining their proprietary ferritin nanoparticle-preS1 (Ferritin-NP-preS1) therapeutic vaccine with a preclinically validated HBV-specific siRNA.
-
NewsBroader antibiotic use could change the course of cholera outbreaks, research suggests
Disease modeling research suggests that, for some cholera outbreaks, prescribing antibiotics more aggressively could slow or stop the spread of the disease and even reduce the likelihood of antibiotic resistance.
-
NewsA hidden control center: How bacteria regulate their attack strategies
Researchers have discovered that a key bacterial protein, CsrA, gathers in a droplet-like structure inside cells to control when and how bacteria activate their disease-causing genes.